Moffitt Cancer Center at Speros Outpatient Center brings the unmatched excellence of the only NCI-designated Comprehensive Cancer Center based in Florida even closer to patients in Pasco County. The state-of-the-art facility is conveniently located right off the Suncoast Parkway in Land O'Lakes, FL.
Designed to expand access for patients across Pasco and surrounding communities, Moffitt at Speros offers a wide range of services, including cancer screenings, chemotherapy, clinical trials, radiation therapy and more, making it easier to receive many of the treatments patients need closer to where they live. Care at Speros seamlessly complements services across all Moffitt campuses, giving patients flexible scheduling and convenient access to frequent appointments.
91,000
square-feet
22
chemotherapy bays
18
exam rooms
4
radiation oncology exam rooms
The Richard M. Schulze Family Foundation Proton Center will open at the same location in summer 2026.
Moffitt is the top-ranked cancer hospital in Florida and the Southeast and ranked No. 15 in the nation in Newsweek’s “America’s Best Cancer Hospitals."
Feel confident choosing Moffitt for your cancer care. Our experts focus exclusively on the evaluation, diagnosis, and treatment of cancer and have an unparalleled level of experience and expertise, which leads to better outcomes and improved quality of life for our patients.
Plus, 99% of Moffitt's providers have received a rating of 4.5 stars or higher from past patients. You can read all the patient comments on their biography pages.
Among other cancer types, appointments are available for:
Program
Genitourinary Oncology
Specialty
Urology
Cancer Focus
Bladder Cancer, Kidney (Renal Cell) Cancer, Prostate Cancer
Program
MMG Ambulatory HemOnc
Specialty
Hematology/Oncology
Cancer Focus
Bladder Cancer, Bladder Cancer, Colon Cancer, Colon Cancer, Colorectal Cancer, Colorectal Cancer, Kidney (Renal Cell) Cancer, Kidney (Renal Cell) Cancer, Lung Cancer, Lung Cancer, Pancreatic Cancer, Pancreatic Cancer, Prostate Cancer, Prostate Cancer, Rectal Cancer, Rectal Cancer
Program
Genitourinary Oncology
Specialty
Urology
Cancer Focus
Bladder Cancer, Kidney (Renal Cell) Cancer, Prostate Cancer
Program
MMG Ambulatory HemOnc
Specialty
Hematology/Oncology
Cancer Focus
Anal Cancer, Appendiceal (Appendix) Cancer, Benign Hematology, Bladder Cancer, Breast Cancer, Colon Cancer, Colorectal Cancer, Ductal Carcinoma In Situ, Esophageal Cancer, Gallbladder Cancer, Hodgkin Lymphoma, Leukemia, Lung Cancer, Non-Hodgkin Lymphoma, Pancreatic Cancer, Prostate Cancer, Rectal Cancer
Program
MMG Ambulatory HemOnc
Specialty
Medical Oncology
Cancer Focus
Lung Cancer, Mesothelioma, Neuroendocrine Tumor, Pancoast Tumor, Thymoma
Specialty
Medical Oncology
Cancer Focus
Anal Cancer, Appendiceal (Appendix) Cancer, Bladder Cancer, Breast Cancer, Colon Cancer, Colorectal Cancer, Esophageal Cancer, Hodgkin Lymphoma, Invasive Ductal Carcinoma, Kidney (Renal Cell) Cancer, Leukemia, Lung Cancer, Melanoma, Multiple Myeloma-Plasma Cell Disorders, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma, Pancreatic Cancer, Prostate Cancer, Rectal Cancer, Small Intestine Cancer, Stomach (Gastric) Cancer, Triple Negative Breast Cancer
Program
MMG Ambulatory HemOnc
Specialty
Hematology/Oncology
Cancer Focus
Bladder Cancer, Kidney (Renal Cell) Cancer, Lung Cancer, Penile Cancer, Prostate Cancer, Testicular Cancer
Program
Gynecologic Oncology
Specialty
Gynecologic Oncology
Cancer Focus
Cervical Cancer, Endometrial (Uterine) Cancer, Ovarian Cancer, Vaginal Cancer, Vulvar Cancer
Program
MMG Ambulatory HemOnc
Specialty
Hematology/Oncology
Cancer Focus
Benign Hematology, Breast Cancer, Ductal Carcinoma In Situ, Hodgkin Lymphoma, Inflammatory Breast Cancer, Non-Hodgkin Lymphoma, Triple Negative Breast Cancer
Program
MMG Ambulatory HemOnc
Specialty
Hematology/Oncology
Cancer Focus
Benign Hematology, Leukemia, Myelodysplastic Syndromes (MDS)
Program
Radiation Oncology
Specialty
Radiation Oncology
Cancer Focus
Brain Cancer, Glioblastoma, Meningioma, Spinal Tumor, Throat Cancer, Thyroid Cancer, Tongue Cancer
Program
MMG Ambulatory HemOnc
Specialty
Hematology/Oncology
Cancer Focus
Benign Hematology, Breast Cancer, Ductal Carcinoma In Situ, Hodgkin Lymphoma, Multiple Myeloma-Plasma Cell Disorders, Non-Hodgkin Lymphoma
Program
MMG Ambulatory HemOnc
Specialty
Hematology/Oncology
Cancer Focus
Esophageal Cancer, Gastrointestinal Carcinoid Tumor, Kidney (Renal Cell) Cancer, Liver (Hepatocellular) Cancer, Lung Cancer, Prostate Cancer, Testicular Cancer
Program
Malignant Hematology
Specialty
Hematology/Oncology
Cancer Focus
Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndromes (MDS)
Program
MMG Ambulatory HemOnc
Specialty
Hematology/Oncology
Cancer Focus
Anal Cancer, Breast Cancer, Cholangiocarcinoma (Bile Duct Cancer), Colon Cancer, Colorectal Cancer, Ductal Carcinoma In Situ, Inflammatory Breast Cancer, Invasive Ductal Carcinoma, Pancreatic Cancer, Rectal Cancer, Triple Negative Breast Cancer
Program
Malignant Hematology
Specialty
Hematology/Oncology
Cancer Focus
Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndromes (MDS)
Program
Radiation Oncology
Specialty
Radiation Oncology
Cancer Focus
Esophageal Cancer, Head and Neck Cancer, Squamous Cell Carcinoma, Throat Cancer, Thyroid Cancer, Tongue Cancer
Program
Breast Oncology
Cancer Focus
Breast Cancer, Ductal Carcinoma In Situ, Inflammatory Breast Cancer, Invasive Ductal Carcinoma, Triple Negative Breast Cancer
Moffitt is committed to holding ourselves to the highest standards, especially in the area of patient satisfaction. We believe in the power of patient choice and want to provide the information a patient needs to make a thoughtful choice when selecting a provider. To help make this information publicly available, we proudly partner with Press Ganey ato provide ratings and comments of our providers.
Opening in June 2026, Moffitt's Richard M. Schulze Family Foundation Proton Center and The Proteus®ONE systen will solidify Moffitt’s Speros campus as a premier health care destination and emerging global hub for research and innovation.
